Appropriated funds for Office of Generic Drugs dries up

Share this article:
FDA's Office of Generic Drugs ran out of appropriated funds April 3 and a hiring freeze was imposed, halting a recently launched aggressive recruitment program aimed at boosting staff by 50% to reduce a backlog.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Novartis apologizes for slow reporting

Novartis is apologizing to Japan after the Ministry of Health, Labor and Welfare said the company had dragged its feet reporting adverse events for two of its cancer drugs.

J&J pulls morcellator from market

The company is calling the move a withdrawal, as opposed to a recall.

Pfizer buys two Baxter vaccines

The meningitis and encephalitis medications earned a combined $300 million last year.